Print View Attached Docs:
87850:NMP-22
Alias Names:Nuclear Matrix Protein-22 Assay
Methodology:Enzyme Immunoassay (EIA)
Edit Date:4/6/2010
Performed:Monday, Thursday
Released:1-6 days after setup at PeaceHealth Laboratories' reference lab
CPT Code:86316-90
Specimen Collection Details
Collection:Single void of urine between midnight an noon.
Handling:Immediately following collection, add urine to NMP22 Urine Stabilizer Vial. Urine stabilization kit available from PeaceHealth Laboratories' Client Services. Stabilized specimen should be blue/green in colour. Freeze.
Stability:48 hours ambient, 72 hours refrigerated, or 1 month frozen.
Standard Volume:5 mL stabilized urine.
Transport:Frozen on dry ice.
Comments:The NMP22® assay is intended as an aid in the management of patients with transitional cell carcinoma of the urinary tract (TCC/UT). It is used after surgical treatment to identify patients with residual or rapidly recurring TCC/UT. NOTE: Values obtained with different assay methods should not be used interchangeably. This test is done using the Matritech NMP22® Test Kit, and enzyme immunoassay (EIA) method.
Rejection Criteria:Non-stabilized urine.
Reference Range:
0.0-10.0 U/mL